Cyclooxygenase 2 Inhibitor Market - Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: C6D6BB559326EN
Market Monitor Global

Abstracts

COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has extremely low activity in normal tissue cells, and can only be produced in large quantities when induced. It mediates pain, inflammation, and fever by promoting PG synthesis. In general, multiple adverse effects of non-steroidal anti-inflammatory drugs are believed to be related to the inhibition of COX-1. As a result, COX-2 selective inhibitors have emerged.

This report contains market size and forecasts of Cyclooxygenase 2 Inhibitor in Global, including the following market information:

Global Cyclooxygenase 2 Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cyclooxygenase 2 Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Selective Cox 2 Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cyclooxygenase 2 Inhibitor include Pfizer, Bayer, Novartis, Merck, Sabinsa, Cadila Pharmaceuticals, Mylan, Teva Pharmaceutical and Alembic Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclooxygenase 2 Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cyclooxygenase 2 Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cyclooxygenase 2 Inhibitor Market Segment Percentages, by Type, 2021 (%)

• Selective Cox 2 Inhibitor
• Non-Selective Cox 2 Inhibitor

Global Cyclooxygenase 2 Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cyclooxygenase 2 Inhibitor Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialty Clinic
• Others

Global Cyclooxygenase 2 Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cyclooxygenase 2 Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cyclooxygenase 2 Inhibitor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cyclooxygenase 2 Inhibitor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Bayer
• Novartis
• Merck
• Sabinsa
• Cadila Pharmaceuticals
• Mylan
• Teva Pharmaceutical
• Alembic Pharmaceutical
• Aurobindo Pharma
• Cipla
• Torrent Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cyclooxygenase 2 Inhibitor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cyclooxygenase 2 Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYCLOOXYGENASE 2 INHIBITOR OVERALL MARKET SIZE

2.1 Global Cyclooxygenase 2 Inhibitor Market Size: 2021 VS 2028
2.2 Global Cyclooxygenase 2 Inhibitor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cyclooxygenase 2 Inhibitor Players in Global Market
3.2 Top Global Cyclooxygenase 2 Inhibitor Companies Ranked by Revenue
3.3 Global Cyclooxygenase 2 Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Cyclooxygenase 2 Inhibitor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cyclooxygenase 2 Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cyclooxygenase 2 Inhibitor Players in Global Market
  3.6.1 List of Global Tier 1 Cyclooxygenase 2 Inhibitor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cyclooxygenase 2 Inhibitor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cyclooxygenase 2 Inhibitor Market Size Markets, 2021 & 2028
  4.1.2 Selective Cox 2 Inhibitor
  4.1.3 Non-Selective Cox 2 Inhibitor
4.2 By Type - Global Cyclooxygenase 2 Inhibitor Revenue & Forecasts
  4.2.1 By Type - Global Cyclooxygenase 2 Inhibitor Revenue, 2017-2022
  4.2.2 By Type - Global Cyclooxygenase 2 Inhibitor Revenue, 2023-2028
  4.2.3 By Type - Global Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cyclooxygenase 2 Inhibitor Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialty Clinic
  5.1.4 Others
5.2 By Application - Global Cyclooxygenase 2 Inhibitor Revenue & Forecasts
  5.2.1 By Application - Global Cyclooxygenase 2 Inhibitor Revenue, 2017-2022
  5.2.2 By Application - Global Cyclooxygenase 2 Inhibitor Revenue, 2023-2028
  5.2.3 By Application - Global Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cyclooxygenase 2 Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Cyclooxygenase 2 Inhibitor Revenue & Forecasts
  6.2.1 By Region - Global Cyclooxygenase 2 Inhibitor Revenue, 2017-2022
  6.2.2 By Region - Global Cyclooxygenase 2 Inhibitor Revenue, 2023-2028
  6.2.3 By Region - Global Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cyclooxygenase 2 Inhibitor Revenue, 2017-2028
  6.3.2 US Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.3.3 Canada Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.3.4 Mexico Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cyclooxygenase 2 Inhibitor Revenue, 2017-2028
  6.4.2 Germany Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.4.3 France Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.4.4 U.K. Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.4.5 Italy Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.4.6 Russia Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.4.7 Nordic Countries Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.4.8 Benelux Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cyclooxygenase 2 Inhibitor Revenue, 2017-2028
  6.5.2 China Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.5.3 Japan Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.5.4 South Korea Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.5.5 Southeast Asia Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.5.6 India Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cyclooxygenase 2 Inhibitor Revenue, 2017-2028
  6.6.2 Brazil Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.6.3 Argentina Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cyclooxygenase 2 Inhibitor Revenue, 2017-2028
  6.7.2 Turkey Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.7.3 Israel Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.7.4 Saudi Arabia Cyclooxygenase 2 Inhibitor Market Size, 2017-2028
  6.7.5 UAE Cyclooxygenase 2 Inhibitor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.1.4 Pfizer Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.2.4 Bayer Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.3.4 Novartis Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.4.4 Merck Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Sabinsa
  7.5.1 Sabinsa Corporate Summary
  7.5.2 Sabinsa Business Overview
  7.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.5.4 Sabinsa Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.5.5 Sabinsa Key News
7.6 Cadila Pharmaceuticals
  7.6.1 Cadila Pharmaceuticals Corporate Summary
  7.6.2 Cadila Pharmaceuticals Business Overview
  7.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.6.4 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.6.5 Cadila Pharmaceuticals Key News
7.7 Mylan
  7.7.1 Mylan Corporate Summary
  7.7.2 Mylan Business Overview
  7.7.3 Mylan Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.7.4 Mylan Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.7.5 Mylan Key News
7.8 Teva Pharmaceutical
  7.8.1 Teva Pharmaceutical Corporate Summary
  7.8.2 Teva Pharmaceutical Business Overview
  7.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.8.4 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.8.5 Teva Pharmaceutical Key News
7.9 Alembic Pharmaceutical
  7.9.1 Alembic Pharmaceutical Corporate Summary
  7.9.2 Alembic Pharmaceutical Business Overview
  7.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.9.4 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.9.5 Alembic Pharmaceutical Key News
7.10 Aurobindo Pharma
  7.10.1 Aurobindo Pharma Corporate Summary
  7.10.2 Aurobindo Pharma Business Overview
  7.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.10.4 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.10.5 Aurobindo Pharma Key News
7.11 Cipla
  7.11.1 Cipla Corporate Summary
  7.11.2 Cipla Business Overview
  7.11.3 Cipla Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.11.4 Cipla Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.11.5 Cipla Key News
7.12 Torrent Pharmaceuticals
  7.12.1 Torrent Pharmaceuticals Corporate Summary
  7.12.2 Torrent Pharmaceuticals Business Overview
  7.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Major Product Offerings
  7.12.4 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue in Global Market (2017-2022)
  7.12.5 Torrent Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cyclooxygenase 2 Inhibitor Market Opportunities & Trends in Global Market
Table 2. Cyclooxygenase 2 Inhibitor Market Drivers in Global Market
Table 3. Cyclooxygenase 2 Inhibitor Market Restraints in Global Market
Table 4. Key Players of Cyclooxygenase 2 Inhibitor in Global Market
Table 5. Top Cyclooxygenase 2 Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cyclooxygenase 2 Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cyclooxygenase 2 Inhibitor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cyclooxygenase 2 Inhibitor Product Type
Table 9. List of Global Tier 1 Cyclooxygenase 2 Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cyclooxygenase 2 Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cyclooxygenase 2 Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cyclooxygenase 2 Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cyclooxygenase 2 Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cyclooxygenase 2 Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Cyclooxygenase 2 Inhibitor Product Offerings
Table 32. Pfizer Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Cyclooxygenase 2 Inhibitor Product Offerings
Table 35. Bayer Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Cyclooxygenase 2 Inhibitor Product Offerings
Table 38. Novartis Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Cyclooxygenase 2 Inhibitor Product Offerings
Table 41. Merck Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 42. Sabinsa Corporate Summary
Table 43. Sabinsa Cyclooxygenase 2 Inhibitor Product Offerings
Table 44. Sabinsa Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 45. Cadila Pharmaceuticals Corporate Summary
Table 46. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Offerings
Table 47. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 48. Mylan Corporate Summary
Table 49. Mylan Cyclooxygenase 2 Inhibitor Product Offerings
Table 50. Mylan Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Corporate Summary
Table 52. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product Offerings
Table 53. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 54. Alembic Pharmaceutical Corporate Summary
Table 55. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product Offerings
Table 56. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 57. Aurobindo Pharma Corporate Summary
Table 58. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product Offerings
Table 59. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 60. Cipla Corporate Summary
Table 61. Cipla Cyclooxygenase 2 Inhibitor Product Offerings
Table 62. Cipla Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)
Table 63. Torrent Pharmaceuticals Corporate Summary
Table 64. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Offerings
Table 65. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cyclooxygenase 2 Inhibitor Segment by Type in 2021
Figure 2. Cyclooxygenase 2 Inhibitor Segment by Application in 2021
Figure 3. Global Cyclooxygenase 2 Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cyclooxygenase 2 Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cyclooxygenase 2 Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2021
Figure 8. By Type - Global Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 12. US Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 16. Germany Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 17. France Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 24. China Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. India Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 30. Brazil Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cyclooxygenase 2 Inhibitor Revenue Market Share, 2017-2028
Figure 33. Turkey Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cyclooxygenase 2 Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sabinsa Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mylan Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cipla Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)